| CXSS2500058 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2025-06-04 | | RemeGen Co Ltd | | | view |
| CYSB2500043 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(1) | Supplementary Application | 2025-02-18 | | RemeGen Co Ltd | | | view |
| CXSS2400111 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2024-10-15 | | RemeGen Co Ltd | | | view |
| CXSL2400306 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2024-05-11 | | RemeGen Co Ltd | | | view |
| CXSL2400037 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.1;2.2) | New Drug Application | 2024-01-18 | | RemeGen Co Ltd | | | view |
| CYSB2300215 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(1) | Supplementary Application | 2023-11-25 | | RemeGen Co Ltd | | | view |
| CXSL2300686 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-10-12 | | RemeGen Co Ltd | | | view |
| CXSL2300486 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-07-18 | | RemeGen Co Ltd | | | view |
| CXSL2300459 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-07-11 | | RemeGen Co Ltd | | | view |
| CYSB2300118 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(1) | Supplementary Application | 2023-06-19 | | RemeGen Co Ltd | | | view |
| CXSL2300319 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-05-08 | | RemeGen Co Ltd | | | view |
| CXSL2300048 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-01-18 | | RemeGen Co Ltd | | | view |
| CXSL2300018 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-01-07 | | RemeGen Co Ltd | | | view |
| CXSL2300019 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.1;2.2) | New Drug Application | 2023-01-07 | | RemeGen Co Ltd | | | view |
| CXSL2300017 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-01-06 | | RemeGen Co Ltd | | | view |
| CXSL2200632 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2022-12-31 | | RemeGen Co Ltd | | | view |
| CXSL2200633 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2022-12-31 | | RemeGen Co Ltd | | | view |
| CXSL2200559 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2022-11-05 | | RemeGen Co Ltd | | | view |
| CXSL2200515 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products(2.2) | New Drug Application | 2022-10-13 | | RemeGen Co Ltd | | | view |
| CYSB2200122 | 注射用维迪西妥单抗 | disitamab vedotin | Lyophilized | Biological Products | Supplementary Application | 2022-05-19 | | RemeGen Co Ltd | | | view |
